Kirby SL - Search Results

1

Cytoprotection by amifostine during autologous stem cell transplantation for advanced refractory hematologic malignancies.

Gabriel DA, Shea TC, Serody JS, Moore DT, Kirby SL, Harvey D, Krasnov C. Gabriel DA, et al. Among authors: kirby sl. Biol Blood Marrow Transplant. 2005 Dec;11(12):1022-30. doi: 10.1016/j.bbmt.2005.08.033. Biol Blood Marrow Transplant. 2005. PMID: 16338625 Free article. Clinical Trial.

2

Comparison of granulocyte colony-stimulating factor (G-CSF)--mobilized peripheral blood progenitor cells and G-CSF--stimulated bone marrow as a source of stem cells in HLA-matched sibling transplantation.

Serody JS, Sparks SD, Lin Y, Capel EJ, Bigelow SH, Kirby SL, Gabriel DA, Wiley JM, Brecher ME, Schell MJ, Folds J, Shea TC. Serody JS, et al. Among authors: kirby sl. Biol Blood Marrow Transplant. 2000;6(4A):434-40. doi: 10.1016/s1083-8791(00)70035-8. Biol Blood Marrow Transplant. 2000. PMID: 10975512 Clinical Trial.

3

Intraindividual variability in busulfan pharmacokinetics in patients undergoing a bone marrow transplant: assessment of a test dose and first dose strategy.

Lindley C, Shea T, McCune J, Shord S, Decker J, Harvey D, Petros WP, Garbriel D, Serody J, Kirby S, Wiley J. Lindley C, et al. Anticancer Drugs. 2004 Jun;15(5):453-9. doi: 10.1097/01.cad.0000127145.50172.51. Anticancer Drugs. 2004. PMID: 15166618 Clinical Trial.

4

Murine T lymphocytes incapable of producing macrophage inhibitory protein-1 are impaired in causing graft-versus-host disease across a class I but not class II major histocompatibility complex barrier.

Serody JS, Cook DN, Kirby SL, Reap E, Shea TC, Frelinger JA. Serody JS, et al. Among authors: kirby sl. Blood. 1999 Jan 1;93(1):43-50. Blood. 1999. PMID: 9864144 Free article.

5

Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning.

Wysocki CA, Burkett SB, Panoskaltsis-Mortari A, Kirby SL, Luster AD, McKinnon K, Blazar BR, Serody JS. Wysocki CA, et al. Among authors: kirby sl. J Immunol. 2004 Jul 15;173(2):845-54. doi: 10.4049/jimmunol.173.2.845. J Immunol. 2004. PMID: 15240671

6

Host absence of CCR5 potentiates dendritic cell vaccination.

Ng-Cashin J, Kuhns JJ, Burkett SE, Powderly JD, Craven RR, van Deventer HW, Kirby SL, Serody JS. Ng-Cashin J, et al. Among authors: kirby sl. J Immunol. 2003 Apr 15;170(8):4201-8. doi: 10.4049/jimmunol.170.8.4201. J Immunol. 2003. PMID: 12682253

7

Hematopoietic stem cells with controllable tEpoR transgenes have a competitive advantage in bone marrow transplantation.

Kirby S, Walton W, Smithies O. Kirby S, et al. Blood. 2000 Jun 15;95(12):3710-5. Blood. 2000. PMID: 10845901 Free article.

8

Antibodies to stem cell marker antigens reduce engraftment of hematopoietic stem cells.

Gilner JB, Walton WG, Gush K, Kirby SL. Gilner JB, et al. Among authors: kirby sl. Stem Cells. 2007 Feb;25(2):279-88. doi: 10.1634/stemcells.2006-0076. Epub 2006 Sep 28. Stem Cells. 2007. PMID: 17008427

9

The therapeutic potential of erythropoietin receptor transgenes.

Kirby SL. Kirby SL. Cytokines Cell Mol Ther. 1999 Jun;5(2):97-104. Cytokines Cell Mol Ther. 1999. PMID: 10515682 Review.

10

Bone marrow: target for gene transfer.

Kirby SL. Kirby SL. Hosp Pract (1995). 1999 Dec 15;34(13):59-62, 69-70, 73-6. doi: 10.3810/hp.1999.12.176. Hosp Pract (1995). 1999. PMID: 10611899 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page